Credits Available: 5.0 AMA PRA Category 1 Credits

Description: The proposed activities will inform clinicians of recent evidence from clinical trials on the efficacy and safety of TROP2-directed antibody-drug conjugates (ADCs) in patients with progressive NSCLC, allowing them to quickly integrate new treatments into their practice when they become available. Clinicians will be updated on HER2 genomic alterations and apply appropriate testing methodologies per the National Comprehensive Cancer Network (NCCN) guidelines for NSCLC. Furthermore, participants will receive education on the successful management of NSCLC, including managing brain metastases, optimal HER2-targeted ADC dosing, and monitoring approaches for treatment-related adverse events (AEs). Finally, the proposed activities aim to educate participants on the importance of targeting HER3 and using HER3-directed ADCs in the management of NSCLC. The initiative will also provide information on the efficacy and safety of these ADCs based on clinical trial data, as well as strategies for recognizing and minimizing treatment-related AEs to enhance therapy adherence and improve patient outcomes.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Physician Assistant
Target Specialties: Oncology

Sita Bhatt

Boston Medical Center

Sita Bhatt, PharmD, BCOP, is a pharmacy specialist at Boston Medical Center in Boston, MA. She earned her Doctor of Pharmacy degree from the University of Florida in Gainesville, FL, and went on to complete an ASHP-accredited PGY1 residency at Cleveland Clinic Florida in Ft. Lauderdale, FL. She then pursued a PGY2 residency in hematology/oncology at Boston Medical Center. After finishing her residency, Dr. Bhatt continued her work at Boston Medical Center, where she practices in both inpatient and outpatient settings. Dr. Bhatt is board-certified hematology/oncology pharmacist with over 3 years of experience in managing cancer patients of varying populations and conditions. She currently serves as the residency program coordinator for their PGY2 hematology/oncology residency, and is an instructor of medicine at Boston University’s College of Medicine.